Skip to content
A Green Sign – Lifestyle
Author:
Gibson Oncology LLC
Gibson Oncology Announces First Patient Completes Initial Treatment Cycle in Phase II Trial of LMP744 for Recurrent Glioblastoma
August 11, 2026